CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 100 enrolled
Drug / intervention
diclofenac potassium 25 mg tablet +1 moredrug
Likely dose
diclofenac potassium 25 mg tabletfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01666197
NCT01666197Phase 4Completed
CompareCT.gov

A Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Potassium 25 mg Tablet Taken Three Times Daily in Subjects With Acute Joint Pain

Novartis·interventional·Posted Aug 16, 2012·Updated Apr 17, 2014

In Brief

A Phase 4 clinical trial evaluating diclofenac potassium 25 mg tablet and placebo for Ankle Sprain. Completed, enrolled 100 participants across 4 sites.

Detailed Summary

The purpose of this study is to evaluate the efficacy of diclofenac potassium 25 mg tablet compared with placebo taken three times a day in subjects with acute ankle sprains under 'in-use' conditions, in particular with regard to pain relief.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnkle Sprain
CountriesGermany
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 16, 2012
Enrollment StartAug 1, 2012
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.9 years ago

Interventions

diclofenac potassium 25 mg tabletdrug

diclofenac potassium 25 mg tablet

placebodrug

placebo